Skip to main content

Table 1 Overview of studies for hypertension included in the final analysis (N = 11)

From: A semi-systematic review on hypertension and dyslipidemia care in Egypt—highlighting evidence gaps and recommendations for better patient outcomes

Search type

Study: first author; publication date

Brief study design

Sample size (N); characteristics

Prevalence

Awareness

Screening

Diagnosis

Treatment

Adherence

Control

Remarks

Data as per the MAPS inclusion criteria

Unstructured

Global Status Report on noncommunicable diseases: 2014

Global status report tracking worldwide progress in prevention and control of NCDs

Adults (18+ years)

26.0%

x

x

x

x

x

x

NA

Supplementary record

Egypt Health Issues Survey: 2015

Cross-sectional survey

N = 16,671; individuals (15–59 years) interviewed in the survey.

17.2% (women)

16.7% (men)

x

x

42.0%

x

x

x

Unstructured

Egypt National STEPwise Survey For Noncommunicable Diseases Risk Factors Report; 2017

National cross-sectional community-based household survey

N = 6680; nationally representative sample of Egyptian adults (15-69 years).

29.5%

x

x

x

x

x

x

Registry of the Egyptian specialized hypertension clinics: patient risk profiles and geographical differences: El Faramawy A; 2019

Nationwide Specialized Hypertension Clinics Registry

N = 4701; controlled hypertension was defined as BP < 140/90 mmHg in hypertensive patients on antihypertensive medications.

x

x

x

x

x

x

27.1%

Data deviates from the MAPS inclusion criteria (year limit: 2010–2019)

Unstructured

Hypertension Prevalence, Awareness, Treatment, and Control in Egypt. Results from the Egyptian National Hypertension Project (NHP): Ibrahim MM; 1995

Cross-sectional nationwide survey

N = 6733; survey participants (25 to 95 years).

26.3%

37.5%

x

x

24.0%

x

8.0%

NA

Patterns and determinants of treatment compliance among hypertensive patients: Youssef RM; 2002

Multistage random sampling technique

N = 316; hypertensive patients attending health insurance clinics for prescription refills were randomly selected and interviewed.

x

x

x

x

x

51.9%

53.2%

Supplementary record

Prevalence and determinants of hypertension unawareness in Egyptian adults: a cross-sectional study of data from the 2015 Egyptian Health Issues Study: Soliman SS; 2020

Cross-sectional study using data from the 2015 Egyptian Health Issues Survey (EHIS)

N = 2869; participants (≥18 years) were included if they measured blood pressure (systolic and/or diastolic pressure ≥ 140/90 mmHg).

x

43.9%

x

x

x

x

22.7%

Data deviates from the MAPS inclusion criteria (definitions/special patient subgroups)

Structured

Lipid profile in Egyptian patients with coronary artery disease: Ibrahim MM; 2013

Retrospective study of patients with CAD

N = 1000; CAD patients ranged from 19 to 90 years.

56.7%

x

x

x

x

x

x

Data extracted from patients with stable CAD or had a history of MI

Control of hypertension with medication: a comparative analysis of national surveys in 20 countries: Ikeda N; 2014

Systematic search of national health examination surveys from 20 countries

N = 3342; Individuals (35–49 years).

12.1%

x

x

64.7%

54.1%

x

39.5%

Hypertension definition is based on Systolic blood pressure (i.e., < 140 mmHg)

Comparative study between elderly and younger patients with acute coronary syndrome: Obaya M; 2015

Retrospective registry

N = 570; ACS patients were divided into 2 groups: elderly ≥ 60 years; younger < 60 years.

49.1

x

x

x

x

x

x

Data extracted from younger patients (< 60 years) presenting with ACS; hypertension not defined

The pattern of risk-factor profile in Egyptian patients with acute coronary syndrome: phase II of the Egyptian cross-sectional CardioRisk project: Reda A; 2019

Multi-center, observational, cross-sectional study of ACS patients

N = 1681; ACS patients (≥18 years) having a history of hypertension or blood pressure (systolic and/or diastolic pressure ≥140/90 mmHg).

59.0%

x

x

x

x

x

x

Data extracted on investigating ACS patients

  1. ACS, acute coronary syndrome; CAD, coronary artery disease; MI, myocardial infarction; NCD, noncommunicable diseases; NA, not applicable